BiotechTubeBiotechTube
Home/Design Therapeutics/Kathleen B. Yates
KB

Kathleen B. Yates

Senior Vice President, Corporate Development and Strategy

Design Therapeutics

Therapeutic Areas

NeurologyRare Genetic DiseasesNeuromuscular

Design Therapeutics Pipeline

DrugIndicationPhase
DT-216Friedreich Ataxia (FRDA)Phase 1
GeneTAC Platform for DM1Myotonic Dystrophy Type 1 (DM1)Preclinical

Leadership Team at Design Therapeutics

JS
Joao Siffert, M.D.
President, Chief Executive Officer, and Director
PS
Pratik Shah, Ph.D.
Executive Chairperson of the Board of Directors
AA
Arthur A. Levin, Ph.D.
Chief Scientific Officer
JS
Javier San Martin, M.D.
Chief Medical Officer
JW
John W. Beck
Chief Financial Officer
MD
Michael D. Ehlers, M.D., Ph.D.
Board Director
CG
Carol G. Gallagher, Pharm.D.
Board Director
AB
Ajay Bansal, Ph.D.
Board Director
KS
Katherine Stueland
Board Director
MD
Michael D. Eklund, M.S., J.D.
Chief Legal Officer and Corporate Secretary
View full Design Therapeutics profile